![Myelin Oligodendrocyte Glycoprotein Peptide (35-55), mouse, rat acetate 60105 3-benzodiazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl phosphonato]oxy}propyl]carbamoyl}ethyl)-1](https://cdn.shopify.com/s/files/1/0389/1897/9723/files/1691979209760.png?v=1691979234)
Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Aug 5 - Aug 10
3-benzodiazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl phosphonato]oxy}propyl]carbamoyl}ethyl)-1
C4H4O4/c1-3-14-26(2)15-6-4-5-7-16-28-20-12-13-21(22(25)17-20)23(27)18-8-10-19(24)11-9-18
in Bayesian network modelling of HeLa cell response to LY303511
which converts oxypurines to uric acid
p53-mutant gliomas is much more sensitive to KU-60019 radiosensitization than wild-type glioma
Myelin Oligodendrocyte Glycoprotein Peptide (35-55), mouse, rat acetate 60105 3-benzodiazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl phosphonato]oxy}propyl]carbamoyl}ethyl)-1Myelin Oligodendrocyte Glycoprotein Peptide (35 55), mouse, rat acetate is a minor component of CNS myelin. Myelin Oligodendrocyte Glycoprotein Peptide (35 55), mouse, rat produces a relapsing remitting neurological disease with extensive plaque like demyelination. Myelin Oligodendrocyte Glycoprotein Peptide (35 55), mouse, rat acetate induces strong T and B cell responses and is highly encephalitogenic. Product information Molecular Weight: 2642. 00